Takeda selects former CRISPR Therapeutics CMO to lead oncology unit; Emile Nuwaysir out at Ensoma
→ A spokesperson for Takeda tells Peer Review that PK Morrow succeeded Chris Arendt as head of oncology on Jan. 29. A few weeks ago …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
